Apures Co., Ltd. (XKON:149300)
South Korea flag South Korea · Delayed Price · Currency is KRW
52.00
+2.00 (4.00%)
At close: Aug 1, 2025, 3:30 PM KST

Apures Company Description

Apures Co., Ltd. engages in the development and commercialization of solutions for the bio and medical industries in South Korea.

It is involved in the development of MICROPIG, which are research and laboratory mini pig species to provide solutions through standardization of biomaterials for medical experiments and development of regenerative medicine treatments, including cell therapy and heterogeneous organs.

The company provides Porcine Primary Cell for in vitro test; and heterogeneous organ technology, a technology that develops and transplants animal tissues and organs to replace human tissues and organs.

It also manufactures and supplies Bio Membrane under the FCM brand, which is a research skin applicable to in vitro tests; and provides CRO services.

The company was formerly known as MediKinetics Co., Ltd. and changed its name to Apures Co., Ltd. in 2019.

Apures Co., Ltd. was founded in 2001 and is headquartered in Pyeongtaek-si, South Korea.

Apures Co., Ltd.
CountrySouth Korea
Founded2001
IndustryBiological Products, Except Diagnostic Substances
CEOChoi Sundeok

Contact Details

Address:
44, Hansan-gil
Pyeongtaek-si, 17792
South Korea
Phone82 3 1684 1508
Websiteapures.com

Stock Details

Ticker Symbol149300
ExchangeKorea New Exchange
Reporting CurrencyKRW
SIC Code2836

Key Executives

NamePosition
Choi SundeokChief Executive Officer